Neurotech International bags $4M to commercialise autism device

Neurotech International Ltd has successfully raised $4 million via a placement of shares at $0.20 each to drive its ongoing commercialisation of the Mente Autism device.

• Source: proactiveinvestors
• 666
• October 18, 2017